Table 5.
HE_GRADE | Num of 90-day adverse outcome (%) | Model I | Model II | Model III | Model IV |
---|---|---|---|---|---|
NO HE | 594 (16.5) | 1.0 | 1.0 | 1.0 | 1.0 |
1 | 36 (28.3) | 2.00 (1.34, 2.97) 0.0004 |
1.95 (1.29, 2.88) 0.003 |
1.95 (1.28, 2.91) 0.0014 |
1.46 (0.90, 2.32) 0.11 |
2 | 52 (38.0) | 3.00 (2.10, 4.30) <0.0001 |
2.94 (2.04, 4.20) <0.0001 |
2.66 (1.82, 3.83) <0.0001 |
1.15 (0.72, 1.81) 0.54 |
3 | 32 (58.2) | 7.10 (4.14, 12.34) <0.0001 |
7.26 (4.21, 12.73) <0.0001 |
7.65 (4.35, 13.56) <0.0001 |
3.37 (1.71, 6.64) 0.0004 |
4 | 14 (70.0) | 11.90 (4.75, 33.70) <0.0001 |
12.66 (5.03, 35.99) <0.0001 |
13.07 (5.05, 38.10) <0.0001 |
10.56 (3.53, 35.62) <0.0001 |
Model I, unadjusted.
Model II, adjusted for age, sex, and etiology.
Model III, adjusted for model II plus cirrhosis, ascites, infection, and gastrointestinal bleeding.
Model IV, adjusted for model III plus total bilirubin, international normalized ratio, and creatinine.